◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksC › CLMT

Calumet Specialty Products Partners (CLMT) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

BASIC MATERIALS · SPECIALTY CHEMICALS · DATA UPDATED 2026-08-23

Calumet Specialty Products Partners (CLMT) operates in the SPECIALTY CHEMICALS industry and is headquartered in Indianapolis, United States with about 1,540 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2025-12-31, CLMT reported $4.1B in revenue and ($34M) in net income.

Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments.

Interactive charts & full statements → Open the CLMT valuation workbench →

CLMT Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$4.6B$4.1B$4.2B$4.2B$4.7B$3.1B$2.3B$3.5B$3.5B$3.8B$3.6B$4.2B$5.8B$5.4B$4.7B$3.1B$2.2B$1.8B$2.5B$1.6B$1.6B
Gross Profit$302M$246M$231M$452M$352M$143M$99M$452M$437M$498M$408M$595M$530M$410M$513M$274M$199M$173M$254M$181M$203M
Gross Margin %6.6%5.9%5.5%10.8%7.5%4.5%4.4%13.1%12.5%13.2%11.3%14.1%9.2%7.6%11.0%8.7%9.1%9.4%10.2%11.1%12.4%
Operating Income (EBIT)$48M$54M$8M$267M$132M($86M)($72M)$76M$123M$158M($40M)$75M$47M$92M$286M$125M$71M$67M$129M$101M$121M
Operating Margin %1.1%1.3%0.2%6.4%2.8%-2.7%-3.2%2.2%3.5%4.2%-1.1%1.8%0.8%1.7%6.1%4.0%3.3%3.6%5.2%6.2%7.4%
Net Income($137M)($34M)($222M)$48M($170M)($255M)($149M)($44M)($55M)($104M)($329M)($139M)($112M)$3M$205M$86M$16M$61M$44M$83M$94M
Net Margin %-3.0%-0.8%-5.3%1.1%-3.6%-8.1%-6.6%-1.3%-1.6%-2.8%-9.1%-3.3%-1.9%0.1%4.4%2.8%0.8%3.3%1.8%5.1%5.7%
EBITDA$25M$238M$164M$418M$104M$16M$83M$202M$236M$331M($40M)$194M$47M$218M$384M$166M$136M$165M$140M$281M$121M
Earnings Per Share (EPS)$-1.55$-0.39$-2.67$0.60$-2.14$-3.23$-1.90$-0.56$-0.71$-1.34$-4.27$-1.86$-1.61$0.05$3.67$2.02$0.46$1.87$1.38$2.88$3.26
Shares Outstanding (M)88M87M83M80M79M79M78M78M78M78M77M75M70M68M56M43M35M32M32M29M29M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CLMT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$1.4B$1.0B$1.0B$1.1B$1.0B$994M$950M$1.1B
Gross Profit$18M($88M)($3M)$374M($44M)($81M)$84M$5M
Gross Margin %1.3%-8.5%-0.3%34.7%-4.2%-8.2%8.8%0.4%
Operating Income (EBIT)($40M)($171M)($63M)$323M($101M)($49M)$23M($57M)
Operating Margin %-2.8%-16.6%-6.1%29.9%-9.8%-4.9%2.4%-5.2%
Net Income($96M)($317M)($37M)$313M($148M)($162M)($41M)($101M)
Net Margin %-6.6%-30.8%-3.6%29.1%-14.4%-16.3%-4.3%-9.1%
EBITDA$22M($348M)$6M$344M($47M)($56M)$32M$3M
Earnings Per Share (EPS)$-1.09$-3.64$-0.43$3.61$-1.70$-1.87$-0.47$-1.18
Shares Outstanding (M)88M87M87M87M87M86M86M86M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CLMT Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$223M$109M($46M)($15M)$101M($44M)$63M$192M$75M($26M)$4M$376M$227M$39M$380M$64M$134M$101M$130M$168M$167M
Capital Expenditures (CapEx)$73M$52M$77M$272M$536M$83M$44M$55M$50M$70M$139M$339M$290M$161M$57M$49M$35M$24M$168M$261M$76M
Free Cash Flow (FCF)$150M$57M($123M)($287M)($436M)($127M)$19M$137M$25M($96M)($135M)$37M($63M)($122M)$323M$14M$99M$77M($37M)($93M)$91M
FCF Margin %3.3%1.4%-2.9%-6.9%-9.3%-4.0%0.8%4.0%0.7%-2.6%-3.8%0.9%-1.1%-2.2%6.9%0.5%4.5%4.2%-1.5%-5.7%5.5%
Dividends Paid$0M$0M$52M$225M$210M$184M$132M$83M$66M$59M$66M$77M$38M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CLMT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$92M($86M)$116M$100M$3M($111M)($3M)($16M)
Capital Expenditures (CapEx)$38M$13M$13M$8M$14M$18M$25M$17M
Free Cash Flow (FCF)$54M($99M)$104M$92M($11M)($128M)($28M)($32M)
FCF Margin %3.7%-9.7%10.0%8.5%-1.1%-12.9%-3.0%-2.9%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CLMT Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$2.8B$2.7B$2.8B$2.8B$2.7B$2.1B$1.8B$1.9B$2.1B$2.7B$2.7B$2.9B$3.1B$2.7B$2.3B$1.7B$1.0B$1.0B$1.1B$679M$530M
Cash & Cash Equivalents$110M$125M$38M$8M$35M$38M$109M$19M$156M$164M$4M$6M$8M$121M$32M$0M$0M$0M$0M$0M$81M
Total Liabilities$3.7B$3.2B$3.2B$3.0B$3.0B$2.5B$1.9B$1.8B$2.0B$2.6B$2.5B$2.3B$2.3B$1.6B$1.4B$1.0B$618M$547M$608M$279M$151M
Total Debt (Short + Long-Term)$2.3B$2.3B$2.2B$2.2B$1.8B$1.7B$1.5B$1.4B$1.6B$2.0B$2.0B$1.8B$1.7B$1.1B$864M$587M$369M$401M$465M$40M$50M
Total Shareholders' Equity($1.1B)($733M)($713M)($492M)($534M)($389M)($138M)$10M($9M)$120M$219M$604M$810M$1.1B$890M$729M$398M$485M$473M$400M$379M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CLMT viewer.

Other Companies in SPECIALTY CHEMICALS

← CLMPAll “C” companiesCLN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.